Imported Panton-valentine leucocidin (PVL)-positive Staphylococcus aureus skin infections: patients' perspective on quality of life and quality of medical care

J Travel Med. 2022 Jul 14;29(4):taac047. doi: 10.1093/jtm/taac047.

Andreas K Lindner^{1

2}, Franziska Hommes¹, Olga Nikolai¹, Gabriela Equihua Martinez¹, Berna Gürer¹, Renate Krüger^{2

3}, Rasmus Leistner^{2

4

5}, Dennis Nurjadi⁶, Frank P Mockenhaupt¹, Philipp Zanger^{6

7}

¹ Charité - Universitätsmedizin Berlin, Institute of Tropical Medicine and International Health, Augustenburger Platz 1, 13353 Berlin, Germany.
² Charité - Universitätsmedizin Berlin, Interdisciplinary workgroup on PVL-positive S. aureus (www.pvl-abszess.de), Berlin, Germany.
³ Charité - Universitätsmedizin Berlin, Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Augustenburger Platz 1, 13353 Berlin, Germany.
⁴ Charité - Universitätsmedizin Berlin, Institute of Hygiene and Environmental Medicine, Hindenburgdamm 27, 12203 Berlin, Germany.
⁵ Charité - Universitätsmedizin Berlin, Medical Department, Division of Gastroenterology, Infectious Diseases and Rheumatology (including Nutritional Medicine), Hindenburgdamm 30, 12203 Berlin, Germany.
⁶ Medical Microbiology and Hygiene, Department of Infectious Diseases, University Hospitals, Im Neuenheimer Feld 324, 69120 Heidelberg, Germany.
⁷ Heidelberg Institute of Global Health (HIGH), University Hospitals, Im Neuenheimer Feld 130/3, 69120 Heidelberg, Germany.

No abstract available

Keywords: PVL; Panton-Valentine leucocidin; Staphylococcus aureus; disease burden; quality of life; returning traveller.

MeSH terms